Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
Date:3/5/2009

341) 341 h - Investment and other income 10,393 (5,422) i 4,971 Interest expense on long-term debt (51,748) 2,242 j (49,506) Write-down and other deferred financing charges - - - Write-down / loss on redemption of investments (8,157) 8,157 m - Write-down of assets held for sale - - - Write-down of goodwill - - - ------------------------------------------------------------------------- ------------------------------------------------------------------------- (49,853) 5,318 (44,535) ------------------------------------------------------------------------- ------------------------------------------------------------------------- (Loss) income from continuing operations before income taxes (70,592) 68,268 (2,324) Income tax (recovery) expense (14,545) 18,066 p 3,521 ------------------------------------------------------------------------- ------------------------------------------------------------------------- (Loss) income from continuing operations (56,047) 50,202 (5,845) Net loss from discontinued operations, net of income taxes (9,893) 9,893 - ------------------------------------------------------------------------- Net (loss) income for the period $ (65,940) $ 60,095 $ (5,845) ------------------------------------------------------------------------- Basic and diluted net (loss) income per common share from continuing operations $ (0.66) $ (0.07) ----------------------------------------------------------
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
2. Angiotech Pharmaceuticals announces time change of conference call and webcast
3. Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners
4. Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
5. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
6. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
7. Angiotech wins before the UK House of Lords
8. Angiotech to Establish Separate Operating and Royalty Businesses
9. Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
10. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
11. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... zFlo Motion , a US leader in biomechanics software ... a new partner. STT-Systems has developed an impressive ... with offerings in the optical-motion capture, 3D scanning, and industrial ... unit), iSen, is opening eyes around the world. With no ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 ... technologies such as the Bioruptor® and complete solutions ... system for chromatin immunoprecipitation, alleviating the need for ... and controls needed for ChIP of histones or ...
(Date:1/22/2015)... Mass. , Jan. 22, 2015   GenoSpace , a ... of tools to enable the broad use of genomic, imaging ... announced the appointment of Michelle Munson , CEO of ... director. Logo - http://photos.prnewswire.com/prnh/20150122/170713 ...
(Date:12/24/2014)... NEW YORK , Dec. 24, 2014 ... patient care in critical areas, announced the closing of an ... warrants to purchase up to an aggregate 3,500,000 shares of ... and $.01 per warrant.  The warrants have a per share ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... Sept. 15 CMS, Inc., an Elekta Company ... management,solutions, today announced the commercial launch of its ... of the Focal product line that also includes ... that support the,visualization and utilization of 4D image ...
... BUFFALO, N.Y., Sept. 15 Kinex Pharmaceuticals announced,that ... Company,s Board of,Directors., Dr. Hsia is a ... a publicly traded company listed in New York ... President, Scientific,Affairs of Watson Pharmaceuticals before his retirement. ...
... -- Sinovac Biotech Ltd. (Amex:,SVA), a leading provider ... clinical trials in Ukraine for its inactivated hepatitis ... being conducted by,Biolik Biopharmaceutical Company, a vaccine manufacturer ... the Country. Biolik will,also market and distribute Healive ...
Cached Biology Technology:CMS, Inc., an Elekta Company, Announces Commercial Availability of Focal4D(TM) 2Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine 2Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine 3
(Date:1/22/2015)... Infinisource has launched its new NXG series of time ... sets a higher standard for collecting attendance and labor data ... plug-and-play installation, touch screen interface and seamless connection to cloud-based ... collection solution for the small to mid-size employer. ...
(Date:12/22/2014)... DUBLIN , Dec. 22, 2014 Research and ... the addition of the "The Global Watermarking ... http://photos.prnewswire.com/prnh/20130307/600769 ... global digital media watermarking and fingerprinting markets. Watermarking ...
(Date:12/19/2014)... Dec. 18, 2014 Research and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ... Monitor: North America Perimeter Security Systems Market" report to ... The North American perimeter security market is estimated to ... Although the U.S. market holds a larger share in this ...
Breaking Biology News(10 mins):Infinisource's NXG series sets new time clock standard 2The Global Watermarking and Fingerprinting Markets 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3
... October 2011 A young scientist who led research into the ... surface disease has been named the winner of the Young Investigator ... will be presented with her award at The Stem Cell Symposium, ... 2011. The $10,000 prize is awarded annually to a young scientist ...
... primary producers of ammonia in Houston,s atmosphere, and cars and ... to a new study by researchers at Rice University and ... quality draws minimal oversight from the Environmental Protection Agency (EPA), ... means to life in and around the metropolis. ...
... microscopical water channels are also present in the cells ... transported through the protective surface of the cell. Scientists at ... of the body,s water channels can be modified such that ... the treatment of several diseases. "It,s important to understand ...
Cached Biology News:Regenerating eyes using cells from hair: Stem Cells awards research into stem cell deficiency 2Ammonia gets overdue overview 2Ammonia gets overdue overview 3Water channels in the body help cells remain in balance 2
Evolutionarily conserved signaling intermediate in Toll pathway...
Phosphatidylinositol transfer protein beta isoform (PtdIns transfer protein beta) (PtdInsTP) (PI-TP-beta). [Source:Uniprot/SWISSPROT;Acc:P48739] Antigen: Recombinant Protein Epitope Signature Tag...
Mouse monoclonal [88B] to nicotinic Acetylcholine Receptor ( Abpromise for all tested applications)....
PPIF Antibody...
Biology Products: